NERV - Minerva Neurosciences GAAP EPS of -$1.26 misses by $0.34
2023-03-08 07:31:55 ET
- Minerva Neurosciences press release ( NASDAQ: NERV ): Q4 GAAP EPS of -$1.26 misses by $0.34 .
- Cash, cash equivalents, and restricted cash as of December 31, 2022 were approximately $36.2 million, compared to $60.9 million as of December 31, 2021.
- In January 2023, we received a refund of our NDA filing fee of $3.1 million from the FDA. This refund was made in accordance with the Federal Food Drug and Cosmetic Act, which allows a fee waiver for a small business submitting its first human drug application.
For further details see:
Minerva Neurosciences GAAP EPS of -$1.26 misses by $0.34